FILTER

FILTERED INTERVIEW RESULTS

Laurie M. Clark

FOUNDER AND CEO, ONYEN CORPORATION
"ESG is ethically and financially necessary for companies in the current environment, so we wanted to help them navigate the complexities of reporting."

Stefan Spears

CHAIRMAN AND CEO, INVENTUS MINING CORP.
"Our focus remains on precious metals, but in some of our drilling, cobalt, copper and nickel contribute a significant portion of the metal value."

Timothy Beale

DIRECTOR, PAMPA METALS
Timonthy Beale outlines Pampa Metals exploration plans in Chile for 2022

Víctor Gobitz

PRESIDENTE, INSTITUTO DE INGENIEROS DE MINAS DEL PERÚ (IIMP)
Víctor Gobitz analyzes the main opportunities and threats for the Peruvian mining industry (Spanish interview)

Alex Black

PRESIDENT & CEO, RIO2 LIMITED
Alex Black discusses development at Rio2’s Fenix Gold project in Chile

Michael Gribbons

PRESIDENT, CEO & CO-FOUNDER, MAESTRO DIGITAL MINE
"One of our major value propositions entails “disruption by elimination” by developing mine hardened multi-variable measurement and devices that eliminate complex PLCs, cabinets, engineering services and wiring."

Chris Novak

CEO, CENTRIC MINING SYSTEMS
"In the same way ESG has made a key appearance, there is a real trend towards analytics."

Sampson Koduah

WEST AFRICA GENERAL MANAGER, INTERTEK MINERALS
"Many new players are joining the market, while those who have kept a low profile over the years are now resurfacing, stronger."

Baafour Asiamah-Adjei

CEO AND FOUNDER, GENSER ENERGY
"Our strategy is to enter the Sahelian countries with a combination of renewable energy and trucked LNG from Ghana."

Jean-Marc Lulin

PRESIDENT & CEO, AZIMUT EXPLORATION
"We consider Patwon one of the largest gold discoveries in Northern Québec since the Éléonore deposit in 2004. A new drilling program this fall is expected to produce a maiden resource."

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.

PARTNER EVENTS